KRYSKrystal Biotech, Inc.vs its industry peers
A metric-by-metric comparison of Krystal Biotech, Inc. against SPDR S&P Biotech ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KRYS본 종목 | $10.0B#3 | 42.2x#1 | 7.3x#5 | 25.6x#1 | 33.9%#3 | 129.7%#1 | 41.5%#1 | 15.1%#2 | 17.2%#1 | — | 118.3%#3 | — |
| MRNA | $58.1B#1 | — | 8.6x#6 | 29.9x#2 | -39.9%#5 | 20.8%#4 | -158.1%#3 | -41.7%#8 | -54.6%#2 | — | — | — |
| ORKA | $6.2B#8 | — | 5.6x#3 | — | — | -25.9%#6 | — | -9.5%#5 | — | — | 529.7%#1 | — |
| KYMR | $9.7B#4 | — | 6.4x#4 | 246.9x#5 | -16.7%#4 | 39.1%#2 | -891.1%#5 | 20.6%#1 | — | — | — | — |
| RVMD | $42.0B#2 | — | 16.1x#7 | — | — | -88.5%#9 | — | -43.4%#9 | — | — | 338.6%#2 | — |
| RYTM | $6.7B#7 | — | 65.4x#9 | 35.5x#3 | 45.8%#2 | 24.6%#3 | -101.2%#2 | -0.2%#4 | -133.8%#3 | — | — | — |
| SLS | $2.4B#10 | — | 17.1x#8 | — | -100.0%#7 | 13.0%#5 | — | -19.5%#7 | — | — | — | — |
| PCVX | $8.7B#6 | — | 3.2x#1 | — | — | -65.2%#8 | — | -0.0%#3 | — | — | — | — |
| DNTH | $5.7B#9 | — | 4.9x#2 | 2815.7x#6 | -67.3%#6 | -91.1%#10 | -8739.3%#6 | -13.9%#6 | — | — | — | — |
| CYTK | $9.6B#5 | — | — | 109.6x#4 | 376.6%#1 | -33.2%#7 | -695.4%#4 | — | — | — | 39.5%#4 | — |
Peer set: top holdings of XBI (SPDR S&P Biotech ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice